Health In Tech, Inc. Files 8-K with Material Agreement

TL;DR

Health In Tech (HIT) filed an 8-K on 12/20/24 detailing a material agreement & financials.

AI Summary

On December 20, 2024, Health In Tech, Inc. entered into a Material Definitive Agreement. The company also made a Regulation FD Disclosure and filed financial statements and exhibits. The filing details are associated with Accession Number 0001213900-24-112472.

Why It Matters

This 8-K filing indicates significant corporate activity, including a material definitive agreement and financial disclosures, which could impact investor understanding of the company's current status and future direction.

Risk Assessment

Risk Level: medium — Material definitive agreements and financial disclosures in an 8-K can signal significant business changes, requiring careful investor review.

Key Numbers

• 001-42449 — SEC File Number (Identifies the company's filing history with the SEC.)
• 87-3545722 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Health In Tech, Inc. (company) — Registrant
• 0001213900-24-112472 (accession_number) — Filing identifier
• December 20, 2024 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• 701 S. Colorado Ave, Suite 1 Stuart, FL 34994 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value per share HIT The Nasdaq
• $4.00 — . The price per Share to the public was $4.00. The Company also granted the Underwrit
• $7.27 m — aggregate net proceeds of approximately $7.27 million, after deducting underwriting dis

Filing Documents

• ea0225895-8k_healthin.htm (8-K) — 28KB
• ea022589501ex1-1_healthin.htm (EX-1.1) — 264KB
• ea022589501ex10-1_healthin.htm (EX-10.1) — 52KB
• ea022589501ex99-1_healthin.htm (EX-99.1) — 7KB
• ea022589501ex99-2_healthin.htm (EX-99.2) — 9KB
• 0001213900-24-112472.txt ( ) — 361KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On December 20, 2024, Health In Tech, Inc., a Nevada corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with American Trust Investment Services, Inc., as representative (the “Representative”) of the several underwriters identified therein, relating to the Company’s initial public offering (the “Offering”) of 2,300,000 shares of the Company’s Class A Common Stock, par value $0.001 per share (the “Shares”). The Company previously filed the form of underwriting agreement as an exhibit to its Registration Statement on Form S-1, as amended from time to time (File No. 333-281853) (the “Registration Statement”). The price per Share to the public was $4.00. The Company also granted the Underwriters a 30-day option to purchase up to 345,000 additional Shares on the same terms and conditions for the purpose of covering any over-allotments in connection with the Offering. On December 24, 2024, the Company consummated the Offering and issued the Shares for aggregate net proceeds of approximately $7.27 million, after deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the Offering, along with its existing cash and cash equivalents, to fund enhancements to the Company’s current systems as well as the development of additional functionalities of its systems, business expansion of the Company’s service offerings, expansion of sales and distribution channels in order to reach a broader customer base, talent development and retention, as well as for working capital and other general corporate purposes. The Shares were offered, issued and sold to the public pursuant to the Registration Statement, which was declared effective by the Securities and Exchange Commission (“SEC”) on December 19, 2024, an

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On December 20, 2024, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. On December 24, 2024, the Company issued a press release announcing the closing of the Offering. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K. 1 The information in this Item 7.01 (including the exhibits) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act or the Exchange Act.

Forward-Looking Statements

Forward-Looking Statements Certain statements in this Current Report on Form 8-K are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, use of net proceeds from the Offering, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 1.1 Underwriting Agreement by and between the Company and the Representative dated December 20, 2024. 10.1 Form of Indemnification Agreement. 99.1 Press release dated December 20, 2024. 99.2 Press release dated December 24, 2024. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 26, 2024 HEALTH IN TECH, INC. By: /s/ Tim Johnson Name: Tim Johnson Title: Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR